Date: 6 November 2026

Financial Performance Summary

Q2 FY27 Financial Highlights:

  • Revenue: ₹2,829 Cr (19% YoY growth)
  • Normalised PAT: ₹281 Cr (34% YoY growth)
  • PAT Margin: 10%
  • ROCE: 23% (increased by 152 bps YoY)

Operational Metrics

Patient Volume and Utilization:

  • Total patients served: 2.2 million (12% YoY growth)
  • Occupancy: 68% (improved 335 bps from 65%)
  • Medical Value Travel (MVT) volume: 31% YoY growth
  • MVT revenue: 36% YoY growth

Specialty Procedure Growth:

  • Robotic surgeries: ~39% growth
  • Kidney transplants: ~31% growth
  • Joint replacements: ~29% growth

Segment Performance

Hospital Portfolio Breakdown (H1 FY27):

  • Mature hospitals: 73% of hospital revenue, 18% YoY growth
  • Emerging hospitals (including Kasargod & Nagarcoil): 62% YoY growth

Geographical Performance:

  • MVT growth led by Maldives and GCC markets
  • Rising contribution from West Africa and other MENA countries

Clinical Capabilities and Accreditation

New Accreditation Achievements:

  • CARE Hospitals, HITEC City, Hyderabad: Received JCI accreditation
  • MIMS Kasargod: Achieved NABH accreditation within first year of operations

New Centers of Excellence Launched:

  • ARISE Robotic Spine Institute at Aster CMI, Bengaluru
  • CARE Cancer Institute at Ramkrishna CARE, Raipur
  • Fetal Medicine Centre of Excellence at Aster Medcity, Kochi

Advanced Procedures Performed:

  • CARE Banjara, Hyderabad: First adaptive Deep Brain Stimulation procedure for Parkinson's disease
  • Aster Medcity, Kochi: Kerala's first liquid nitrogen cryoablation for breast fibroadenomas

Corporate Development

Merger Completion:

  • First full quarter as combined entity following merger of Aster DM Healthcare and Quality Care India
  • Merger completed on July 1, 2026
  • Combined network: 38 hospitals across 27 cities with over 10,840 beds
  • Unified culture initiative "GO GREATER" launched across nearly 40 locations

ESG and CSR Recognition:

  • Received awards at Global ESG Awards 2026 for:
  • Supporting economically weaker sections
  • Renewable energy integration
  • CSR excellence
  • Continued focus through Aster Volunteers program for underserved communities

Future Outlook

Expansion Plans:

  • Progressing Aster Trivandrum project towards commissioning
  • Focus on expanding CONGO and other high-end specialties
  • Augmenting capacity across geographies
  • Strengthening clinical talent
  • Improving access to quality healthcare

Strategic Priorities:

  • Deliver better patient outcomes
  • Strengthen operational excellence
  • Create sustainable long-term value for all stakeholders
  • Unlock full potential of combined network

Management Commentary

Dr. Azad Moopen, Executive Chairman: Emphasized successful integration progress, strong financial performance, clinical quality achievements, and ESG commitment during first 100 days as combined entity.

Mr. Varun Khanna, Managing Director & Group CEO: Highlighted successful organizational integration, cultural alignment, strong operational metrics, and focus on leveraging combined network potential for future growth.